The chief executive of San Diego-based magnetic source imaging developer Biomagnetic Technologies stepped down last month. James Schumacher, a GE Medical Systems veteran who led BTI since 1993, will be replaced as president and CEO by Scott Buchanan.
The chief executive of San Diego-based magnetic source imaging developer Biomagnetic Technologies stepped down last month. James Schumacher, a GE Medical Systems veteran who led BTI since 1993, will be replaced as president and CEO by Scott Buchanan. Schumacher remains on BTI's board, while the company's office of chairman will remain vacant.
The move was part of BTI's effort to cut costs by reducing management overhead, Schumacher said. BTI implemented a restructuring earlier this year after a delay in shipments of its Magnes 2500 Whole Head system resulted in a revenue shortfall (SCAN 2/5/97).
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.